Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |